LifeVantage (LFVN)

• Market cap: $265M
• 1 day: -5.54%
• 5 days: -11.91%
• 1 month: 20.71%
• 3 months: 73.16%
• 6 months: 158.68%
• Year to date: 19.82%
• 1 year: 298.49%
• 5 years: 29.18%
• 10 years: 139.91%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

Employees: 222

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

1,814% more call options, than puts

Call options by funds: $536K | Put options by funds: $28K

467% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 3

138% more capital invested

Capital invested by funds: $19.2M [Q2] → $45.6M (+$26.4M) [Q3]

36% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 11

20% more funds holding

Funds holding: 55 [Q2] → 66 (+11) [Q3]

7.13% more ownership

Funds ownership: 23.5% [Q2] → 30.63% (+7.13%) [Q3]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $26 23% upside
• Avg. target: $31 44% upside
• High target: $35 65% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

Craig-Hallum Alex Fuhrman 50% 1-year accuracy 5 / 10 met price target	65% upside $35	Buy Initiated	14 Jan 2025
Lake Street Brooks O'Neil 36% 1-year accuracy 5 / 14 met price target	23% upside $26	Buy Initiated	19 Dec 2024